Table 4 Descriptive, treatment and intermediate outcome measures by ethnic group
From: Ethnic inequalities in the treatment and outcome of diabetes in three English Primary Care Trusts
Ethnic Group N (%) | ||||||
|---|---|---|---|---|---|---|
White | South Asian | Black African/Afro-Caribbean | Other | Not recorded | p-value* | |
Descriptive Measures | ||||||
Mean Age | 65.4 | 59.7 | 62.8 | 58.9 | 61.8 | p < 0.001 |
Median (IQR) | (54.2–74.4) | (50.2–67.6) | (52.3–69.4) | (49.4–67.9) | (49.2–71.7) | |
Sex N (%) | ||||||
Male | 3463 (55.4) | 3140 (56.6) | 778 (45.9) | 750 (53.7) | 3507 (54.4) | p < 0.001 |
Female | 2775 (44.4) | 2381 (42.9) | 913 (53.8) | 638 (45.7) | 2900 (45.0) | |
Not recorded | 15 (0.2) | 30 (0.5) | 6 (0.4) | 9 (0.6) | 38 (0.6) | |
Mean BMI | 28.7 | 27 | 28.5 | 27.3 | 27.3 | p < 0.001 |
Median(IQR) | (25.2–33.0) | (24.3–30.4) | (25.5–32.2) | (24.6–31.1) | (24.2–31.2) | |
Not recorded N(%) | 870(13.9) | 495(8.9) | 233 (13.73) | 195 (14.0) | 2361(36.6) | |
Smoker N(%) | 1152 (18.4) | 389 (7.0) | 190 (11.2) | 179 (12.8) | 822 (12.8) | p < 0.001 |
Not recorded | 281 (4.5) | 430 (7.8) | 82 (4.8) | 94 (6.7) | 1508 (23.4) | p < 0.001 |
Treatment Measures | ||||||
On insulin N (%) | 443 (7.1) | 263 (4.7) | 126 (7.4) | 80 (5.7) | 592 (9.2) | p < 0.001 |
On statins N (%) | 1860 (29.8) | 1744 (31.4) | 425 (25.0) | 399 (28.6) | 1405 (21.8) | p < 0.001 |
Intermediate Outcome Measures | ||||||
HbA1c < 7.4 N (%) | 2368 (37.9) | 1423 (25.6) | 540 (31.8) | 438 (31.4) | 1354 (21.0) | p < 0.001 |
Not recorded | 1100 (17.6) | 1377 (24.8) | 313 (18.4) | 320 (22.9) | 3248 (50.4) | |
BP < = 145 N (%) | 4094 (65.5) | 3711 (66.9) | 1095 (64.5) | 995 (71.2) | 3604 (55.9) | p < 0.001 |
Not recorded | 119 (1.9) | 57 (1.0) | 21 (1.2) | 32 (2.3) | 1035 (16.1) | |
Cholesterol < = 5 N(%) | 2537 (40.6) | 2275 (41.0) | 711 (41.9) | 580 (41.5) | 1609 (25.0) | 0.038 |
Not recorded | 1056 (16.9) | 1154 (20.8) | 265 (15.6) | 226 (16.2) | 2953 (45.8) | p < 0.001 |